Skip to main content
. 2018 Feb 27;2018:9638797. doi: 10.1155/2018/9638797

Table 1.

Demographic characteristics of examined cohort.

Examined (40) Control (36) Difference and significance
Age (yrs., mean ± SD) 47.88 ± 6.07 47.07 ± 6.68 NS
Sex (male/female) 22/18 16/14 NS
Body mass index (BMI, kg/m2, mean ± SD) 32.04 ± 6.67 22.18 ± 4.43 p < 0.001
Diabetes type 2 (yes/no) 12/28 9/27 NS
Hypertension (yes/no) 32/8 16/20 p < 0.0001 
Spearman correlation NAFLD + and hypertension,
p < 0.0001
HDL/LDL ratio (mean ± SE) 4.49 ± 0.23 2.94 ± 0.18 p < 0.0001
Status according to BMI:
Normal 5 21 p = 0.000028
Overweight 15 11
Obese 20 4
Metabolic syndrome (yes/no) 34/6 8/28 Chi square,
p < 0.00001
MoCA score (mean ± SD) 24.07 ± 3.18 27.17 ± 2.35 p < 0.001
Total brain volume (cm3, mean ± SD) 1388 ± 127.98 1417 ± 191.83 NS
Gray matter volume (gmw in cm3 mean ± SD) 405 ± 37.42 414 ± 56.09 NS
White matter volume (wmw, in cm3 mean ± SD) 338 ± 31.21 344 ± 46.83 NS
Lateral ventricle volume, right/left (lvlr, lvll, in cm3 mean ± SD) 5.97 ± 0.61 6.07 ± 0.62 5.64 ± 0.37 5.63 ± 0.37 p = 0.009 p < 0.001
AST (U/l, mean ± SE) 39.97 ± 2.61 24.03 ±3.26 p < 0.001
ALT (U/l mean ± SE) 39.11 ± 2.86 36.71 ± 3.5 NS
AST/ALT ratio (mean ± SE) 1.13 ± 0.11 0.7 ± 0.06 p = 0.01
C-reactive protein (mg/l, mean ± SE) 3.96 ± 0.45 3.52 ± 0.51 NS
Fasting glycaemia (mmol/l, l mean ± SE) 5.8 ± 0.19 3.71 ± 0.25 p < 0.001
Triglycerides (mmol/l, l mean ± SE) 2.87 ± 0.18 1.71 ± 0.17 p < 0.001

NS, not significant; SE, standard error. Lateral ventricle volumes.